| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a8354f077dc82e049a7e9a040891d3b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate |
2020-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5862c064ebbed88cd075b7e1f74bf85a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6807e2fee4e7c63e8eeb78a3e4e2464c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4436dbcd479ceced13b6ead9a2ddd170
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b5fe37f1efe88e7a26ddeb575d0ac9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc12a20e60fe7e62ec9f0ac4f512d6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b43a94063668dba2c2d9a6c41e341e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bf343a33e212571fd8ac304a14fd530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ff741eb4b36a72c44a6131046087d12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2412738e869156d5bafc2c3c2108eb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60e3f3d45d0a8133e23ff3ec8b5fa17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29683348ccdeb656690ec04074645279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb8ba4e7cfa57f6afde77e301946eeb6 |
| publicationDate |
2023-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2023000947-A1 |
| titleOfInvention |
Insulinotropic and glucagonotropic effects of beta-lactoglobulin |
| abstract |
The present invention pertains to a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for use in preventing and/or treating a metabolic disorder and/or muscle atrophy. It also pertains to a method of preventing and/or treating a metabolic disorder and/or muscle atrophy in a subject. It furthermore pertains to use of a) beta-lactoglobulin or b) a nutritional composition comprising beta-lactoglobulin for increasing the level of insulin and/or glucagon in the blood of a subject and the present invention also pertains to a non-therapeutic use or method of a) beta-lactoglobulin orb) a nutritional composition comprising BLG. It also pertains to beta-lactoglobulin (BLG) for use in preventing and/or treating diabetes or prediabetes in a subject. It furthermore pertains to a nutritional composition for use in preventing and/or treating diabetes or prediabetes in a subject. |
| priorityDate |
2019-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |